# FDA recall D-0315-2023

> **Sentara Infusion Services** · Class II · drug recall initiated 2022-12-27.

## Product

PIPERACILLIN / TAZOBACTAM (a) 4.5GM IN NS 100 ML, (b)18GM IN NS 267M, (c) 27GM IN NS 400ML, (d) 3.375 GM IN NS 50ML, (e) 36 GM IN NS 533 ML,  antibiotic, Rx only, use with a Curlin or home pump or no pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320

## Reason for recall

Lack of sterility assurance

## Distribution

Dispensed to Patients Nationwide.

## Key facts

- **Recall number:** D-0315-2023
- **Recalling firm:** Sentara Infusion Services
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-12-27
- **Report date:** 2023-02-22
- **Termination date:** 2026-02-20

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Chesapeake, VA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0315-2023

## Citation

> AI Analytics. FDA recall D-0315-2023. Retrieved 2026-06-09 from https://api.ai-analytics.org/recall/D-0315-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*